Amedisys Clears Technical Benchmark, Hitting 80-Plus RS Rating
One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Amedisys (AMED) cleared that benchmark Monday, with a jump from 79 to 84 Monday. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. This unique rating identifies technical performance by using a 1 (worst) to 99 (best) score that shows how a stock’s price action over the trailing 52 weeks matches up against that of all other stocks. Decades of market research reveals that the stocks that go on to make the biggest gains often have an RS Rating of at least 80 in the early stages of their moves.
Amedisys is trying to complete a consolidation with a 218.54 buy point. See if the stock can break out in volume at least 40% above average. It’s a later-stage pattern, and investors should be aware that those involve more risk.